Eli Lilly said Wednesday that it expects to start selling its own oral weight-loss medication in the second quarter of this year, assuming it gets approved by the FDA, which would add another competitor to Novo Nordisk's Wegovy pill and Hims & Hers' new compounded pill
top of page Shop the GLP-1 Products Collection the GLP-1 Newsroom Blog & News Page GLP-1 Newsroom is your go-to source for breaking news, expert updates, trends, products, and real-world insights on everything related to GLP-1 medications, journeys, and diets
This has led to a substantial rise in prescriptions for weight loss among patients without diabetes
If another group plan declined coverage, attach the decline notice (and for renewals, a current decline notice is required)
That is fast
Allow refrigerated vials to reach room temperature for 15-20 minutes before injection to reduce injection site discomfort